These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 12969811

  • 21. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.
    Cruz MA, Whitelock J, Dong JF.
    Thromb Haemost; 2003 Dec; 90(6):1204-9. PubMed ID: 14652658
    [Abstract] [Full Text] [Related]

  • 23. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M, Lämmle B.
    Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
    [Abstract] [Full Text] [Related]

  • 24. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B.
    Blood; 1997 May 01; 89(9):3097-103. PubMed ID: 9129011
    [Abstract] [Full Text] [Related]

  • 25. Thrombotic thrombocytopenic purpura.
    Lämmle B, Kremer Hovinga JA, Alberio L.
    J Thromb Haemost; 2005 Aug 01; 3(8):1663-75. PubMed ID: 16102032
    [Abstract] [Full Text] [Related]

  • 26. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
    Furlan M, Robles R, Solenthaler M, Lämmle B.
    Blood; 1998 Apr 15; 91(8):2839-46. PubMed ID: 9531594
    [Abstract] [Full Text] [Related]

  • 27. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
    Lotta LA, Lombardi R, Mariani M, Lancellotti S, De Cristofaro R, Hollestelle MJ, Canciani MT, Mannucci PM, Peyvandi F.
    J Thromb Haemost; 2011 Sep 15; 9(9):1744-51. PubMed ID: 21726405
    [Abstract] [Full Text] [Related]

  • 28. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
    Marques MB, Mayfield CA, Blackall DP.
    Am J Clin Pathol; 2004 Jun 15; 121 Suppl():S89-96. PubMed ID: 15298154
    [Abstract] [Full Text] [Related]

  • 29. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
    Mori Y, Wada H, Gabazza EC, Minami N, Nobori T, Shiku H, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y.
    Transfusion; 2002 May 15; 42(5):572-80. PubMed ID: 12084165
    [Abstract] [Full Text] [Related]

  • 30. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.
    Delmas Y, Helou S, Chabanier P, Ryman A, Pelluard F, Carles D, Boisseau P, Veyradier A, Horovitz J, Coppo P, Combe C.
    BMC Pregnancy Childbirth; 2015 Jun 17; 15():137. PubMed ID: 26081109
    [Abstract] [Full Text] [Related]

  • 31. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
    Rick ME, Austin H, Leitman SF, Krizek DM, Aronson DL.
    Am J Hematol; 2004 Feb 17; 75(2):96-100. PubMed ID: 14755376
    [Abstract] [Full Text] [Related]

  • 32. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C, Stapenhorst L, Simon T, Budde U, Schneppenheim R, Hoppe B.
    Kidney Int; 2004 Sep 17; 66(3):955-8. PubMed ID: 15327386
    [Abstract] [Full Text] [Related]

  • 33. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease).
    Mannucci PM, Karimi M, Mosalaei A, Canciani MT, Peyvandi F.
    Haematologica; 2003 Apr 17; 88(4):454-8. PubMed ID: 12681973
    [Abstract] [Full Text] [Related]

  • 34. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M, McDaniel JK, Zheng XL.
    J Thromb Haemost; 2017 Oct 17; 15(10):1889-1900. PubMed ID: 28662310
    [Abstract] [Full Text] [Related]

  • 35. Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood.
    Tsai HM, Sarode R, Downes KA.
    Thromb Res; 2002 Nov 01; 108(2-3):121-5. PubMed ID: 12590947
    [Abstract] [Full Text] [Related]

  • 36. Platelets: thrombotic thrombocytopenic purpura.
    George JN, Sadler JE, Lämmle B.
    Hematology Am Soc Hematol Educ Program; 2002 Nov 01; ():315-34. PubMed ID: 12446430
    [Abstract] [Full Text] [Related]

  • 37. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13.
    Kostousov V, Fehr J, Bombeli T.
    Thromb Res; 2006 Nov 01; 118(6):723-31. PubMed ID: 16430944
    [Abstract] [Full Text] [Related]

  • 38. [TTP/HUS and VWF/ADAMTS-13].
    Fujimura Y.
    Rinsho Ketsueki; 2003 Dec 01; 44(12):1144-53. PubMed ID: 14978930
    [No Abstract] [Full Text] [Related]

  • 39. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL.
    Annu Rev Med; 2002 Dec 01; 53():75-88. PubMed ID: 11818464
    [Abstract] [Full Text] [Related]

  • 40. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Robertson MD, Zumberg M.
    Am J Hematol; 2007 Mar 01; 82(3):224-8. PubMed ID: 17034025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.